Biosense Webster, Inc.

Biosense Webster, Inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on September 7, 2023 and the most recent on February 20, 2026 (CARTO™ 3 EP Navigation System V8.4). Its most common review panel is Cardiovascular (2 devices).